Killeen RM, Davy CL, Bauserman SC
Triple agonists add glucagon receptor activation, which: Increases resting energy expenditure by 8% to 12% (Jall et al., Diabetes Care 2024) Promotes hepatic fat oxidation and reduces steatosis May offset some of the lean mass loss seen with GLP-1 monotherapy (early signal, not yet confirmed in long-term trials) The weight loss ceiling for retatrutide appears to be 24% to 26% based on phase 3 data, though long-term real-world outcomes are not yet available
Weight Regain and Discontinuation: What Happens After Stopping GLP-1 Discontinuing GLP-1 therapy without lifestyle changes typically results in gradual weight regain over 612 months, though many patients retain 5070% of their weight loss if diet and exercise habits remain strong
Besides, your body likes fat, even if you dont
Pairing with Vitamin C may accelerate results
Your ability to absorb vitamin B12 depends if you have enough of a protein called intrinsic factor (IF) in your stomach
